Article ID Journal Published Year Pages File Type
8522502 Saudi Pharmaceutical Journal 2018 23 Pages PDF
Abstract
The 2010 FDA bisphosphonates safety communication appeared to have influenced Osteoporosis utilization in Medicaid recipients. The 2010 FDA bisphosphonates safety communication was associated with a significant reduction in the utilization of bisphosphonates in the Medicaid program.
Keywords
Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmaceutical Science
Preview
Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication
Authors
, , ,